Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 7/20 | 0.34 |
| ▸ | GLB1 | P16278 | 1/20 | 0.34 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.34 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.33 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.33 |
| ▸ | GUSB | P08236 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11807350 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL322316 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL8031986 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL8038131 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL9955184 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL8034064 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL5986996 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL9955799 | 1.00 | PSMD14 (0.34) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL8035780 | 0.94 | PSMD14 (0.40) | PSMD14MMP2RAD52GBA1GLB1 | |
| SCHEMBL8032041 | 0.94 | PSMD14 (0.40) | PSMD14MMP2RAD52GBA1GLB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978952-A | Antistatic and dustproof coating for photovoltaic module and preparation method thereof | 珠海城市职业技术学院 | 2025-05-13 | — | — | CN | claimed |
| CN-119799148-A | Water-based silver paint for building installation pipeline and preparation method thereof | 天元建设集团有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-118755468-B | Acidizing corrosion inhibitor for oil and gas well fracturing and preparation method thereof | 延长油田股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119188014-A | High-reliability composite solder paste and preparation and use methods thereof | 广州汉源微电子封装材料有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-116024831-B | Superfine fiber leather soaping fastness improver and preparation method thereof | 太仓宝霓实业有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118755468-A | Acidizing corrosion inhibitor for oil and gas well fracturing and preparation method thereof | 延长油田股份有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-116356602-B | Recyclable switch-type titanium dioxide special for papermaking and preparation method thereof | 河南佰利联新材料有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-117265870-A | Drying and softening fragrant clothing tablet based on papermaking fibers and preparation method thereof | 江苏理文造纸有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-116356602-A | Recyclable switch-type titanium dioxide special for papermaking and preparation method thereof | 河南佰利联新材料有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-116024831-A | Superfine fiber leather soaping fastness improver and preparation method thereof | 太仓宝霓实业有限公司 | 2023-04-28 | — | — | CN | claimed |
| US-20030133966-A1 | Inhibition of exoprotein production in non-absorbent articles using aromatic compositions | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-17 | — | — | US | claimed |
| US-20030135173-A1 | Inhibition of exoprotein production in absorbent articles using aromatic compositions | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-17 | — | — | US | claimed |
| US-20030134897-A1 | Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-07-17 | — | — | US | claimed |
| US-20030105439-A1 | Inhibition of exoprotein production in absorbent articles using isoprenoids | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-06-05 | — | — | US | claimed |
| US-20030096877-A1 | Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions | KIMBERLY-CLARK WORLDWIDE, INC. | 2003-05-22 | — | — | US | claimed |
| WO-2003030953-A1 | INHIBITION OF EXOPROTEIN PRODUCTION USING AROMATIC COMPOSITIONS | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-04-17 | — | — | WO | claimed |
| EP-1103275-A1 | Inhibition of exoprotein in absorbent article | Kimberly-Clark Worldwide, Inc. (US) | 2001-05-30 | — | — | EP | claimed |
| EP-0846005-A2 | INHIBITION OF EXOPROTEIN IN ABSORBENT ARTICLE | Kimberly-Clark Worldwide, Inc. (US) | 1998-06-10 | — | — | EP | claimed |
| US-5618554-A | Inhibition of exoprotein using amine compositions in absorbent article and method thereof | KIMBERLY-CLARK CORPORATION (US) | 1997-04-08 | — | — | US | claimed |
| WO-1996040300-A2 | INHIBITION OF EXOPROTEIN IN ABSORBENT ARTICLE | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 1996-12-19 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096877-A1 | Inhibition of exoprotein production in non-absorbent articles using isoprenoid compositions | FNTA, FNTB, GGPS1 | PSMD14 447/4885MMP2 593/4885RAD52 3452/4885 |
| US-20030133966-A1 | Inhibition of exoprotein production in non-absorbent articles using aromatic compositions | EXOC1, EXOC3, EXOC4 | PSMD14 910/4885MMP2 271/4885RAD52 2946/4885 |
| US-20030134897-A1 | Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria | EXOC1, EXOC3, EXOC4 | PSMD14 401/4885MMP2 2339/4885RAD52 3035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.